Sandeep Sanga, Ph.D. - Publications

Affiliations: 
2009 Biomedical Engineering University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Biomedical Engineering, Bioinformatics Biology, Oncology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Amin A, Sanga S, Gan S, Hu Y, Broudy T. Abstract 2472: LOCUS: Queryable database of cancer genomics and pharmacologic response enables rapid selection of in vitro and in vivo preclinical tumor models Cancer Research. 79: 2472-2472. DOI: 10.1158/1538-7445.Sabcs18-2472  0.469
2019 Amin A, Sanga S, Gan S, Li R, Blewett T, Wang Z, Broudy TB. Abstract B070: LOCUS database enables rapid query and targeted selection of preclinical tumor models based on cancer genomics and pharmacologic response Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-B070  0.469
2015 Sanga S, Vladimirova A, Goold RD, Klingler TM. Abstract 4870: GenePool: A cloud-based technology for rapidly data mining large-scale, patient-derived cancer genomic cohorts including The Cancer Genome Atlas Cancer Research. 75: 4870-4870. DOI: 10.1158/1538-7445.Am2015-4870  0.338
2014 Sanga S, Nair P, Mirsaidi C, Broudy T. Abstract 4279: Rapid biomarker discovery using large-scale, patient-derived cancer genomic cohorts Cancer Research. 74: 4279-4279. DOI: 10.1158/1538-7445.Am2014-4279  0.443
2013 Broudy T, Sanga S, Ricono J, Trikha M, Mirsaidi C, Praveen KN. Abstract 1138: Rapid validation of a novel kinase target using a large scale genomic database and matched patient derived tumor models. Cancer Research. 73: 1138-1138. DOI: 10.1158/1538-7445.Am2013-1138  0.427
2009 Sanga S, Broom BM, Cristini V, Edgerton ME. Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family. Bmc Medical Genomics. 2: 59. PMID 19747394 DOI: 10.1186/1755-8794-2-59  0.539
2009 Sinek JP, Sanga S, Zheng X, Frieboes HB, Ferrari M, Cristini V. Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. Journal of Mathematical Biology. 58: 485-510. PMID 18781304 DOI: 10.1007/S00285-008-0214-Y  0.53
2009 Edgerton M, Chuang Y, Macklin P, Sanga S, Kim J, Tamaiuolo G, Yang W, Broom A, Do K, Cristini V. Using mathematical models to understand the time dependence of the growth of ductal carcinoma in situ. Cancer Research. 69: 1165. DOI: 10.1158/0008-5472.Sabcs-1165  0.558
2009 Chen TC, Sanga S, Chou TY, Cristini V, Edgerton ME. Neural network with K-means clustering via PCA for gene expression profile analysis 2009 Wri World Congress On Computer Science and Information Engineering, Csie 2009. 3: 670-673. DOI: 10.1109/CSIE.2009.945  0.47
2009 Edgerton ME, Chuang Y, Macklin PT, Kim J, Tomaiuolo G, Broom AD, Sanga S, Cristini V. Grap2 and Cyclin-D Interacting Protein (GCIP) Nuclear Expression Is Significantly More Frequent in Triple-Negative Breast Carcinomas (TNBCs) than Other Subtypes of Breast Carcinomas Modern Pathology. 22. DOI: 10.1038/Modpathol.2008.210  0.482
2007 Sanga S, Frieboes HB, Zheng X, Gatenby R, Bearer EL, Cristini V. Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth. Neuroimage. 37: S120-34. PMID 17629503 DOI: 10.1016/J.Neuroimage.2007.05.043  0.571
2007 Sinek JP, Frieboes HB, Sivaraman B, Sanga S, Cristini V. Mathematical and Computational Modeling: Towards the Development and Application of Nanodevices for Drug Delivery Nanotechnologies For the Life Sciences. DOI: 10.1002/9783527610419.Ntls0036  0.55
2006 Sanga S, Sinek JP, Frieboes HB, Ferrari M, Fruehauf JP, Cristini V. Mathematical modeling of cancer progression and response to chemotherapy. Expert Review of Anticancer Therapy. 6: 1361-76. PMID 17069522 DOI: 10.1586/14737140.6.10.1361  0.56
Show low-probability matches.